A master's degree in public health, and four years of experience in the development of marketing and informational materials, writing/research, project management and/or information technology, OR an equivalent combination of education, training, and experience. Experience refers to paid or unpaid, including volunteer work done through National Service programs (Peace Corps, AmeriCorps) or other organizations (e.g. professional, philanthropic, religious, spiritual, community, student or social). PREFERRED QUALIFICATIONS:

Experience in global health, or a related field Strong project management skills and experience leading cross-functional teams Proficiency in digital communication tools, social media platforms, and content management systems Advanced slide deck/presentation development skills Excellent written and verbal communication skills, with a focus on technical writing, cross-cultural sensitivity, storytelling and/or advocacy Proven success in designing and creating effective communications products, website content, and related collateral to reach intended audience(s) Proven ability to synthesize information to develop clear messaging on highly technical subjects for a variety of target audiences Ability to work independently and collaboratively in a fast-paced, multicultural environment Ability to undertake domestic and international travel (up to 15%), including weekends

The International Trachoma Initiative (ITI) is a partner in the global program to eliminate trachoma as a public health problem. ITI supports the Global Program through the donation of the antibiotic azithromycin provided by Pfizer; data management; and advocacy through partnerships. An opportunity at ITI is an opportunity to work at the intersection of global health programs, policy, and advocacy. As a result of its expertise in supply chain systems management, database management, and the ability to build and strengthen partnerships, in August 2024, ITI was awarded a grant by the Gates Foundation to expand its role to support the promotion of child survival. This effort aims to reduce all- cause child mortality through mass drug administration of azithromycin to children under 5 in three selected countries: Niger, Nigeria, and Mali through 2028.